Medical News

RSS

Novel gene rejuvenation therapy preserves cell identity while reversing age

Every organ and tissue progressively loses function and integrity as it ages. In fact, researchers have identified "hallmarks of aging" that not only present specific processes impacted by age, but are also thought of as levers that, if successfully targeted, could help turn back the aging clock and result in tissue rejuvenation.

14 Oct 2026

Common blood pressure drug boosts brown adipose tissue activity and metabolism

Scientists have discovered that the drug losartan, commonly prescribed for high blood pressure, boosts brown adipose tissue activity in mice, enhancing their metabolism.

14 Oct 2026

UC San Diego study achieves mind control by stimulating neurons

When learning how to perform new movements, our brains etch the details in our minds as we master the new task.

14 Oct 2026

Novel bioprinting technique successfully replicates mature human fat tissue

A research team has developed a support-bath bioprinting method that enables fragile, mature human adipocytes to be incorporated into geometrically defined three-dimensional (3D) constructs while retaining their viability, characteristic lipid-filled morphology, and metabolic activity.

14 Oct 2026

Opioid use disorder diagnoses spike among commercially insured Americans

Commercially insured patients with diagnoses of opioid use disorder increased 32.7 percent nationally from 2022 to 2025, according to FAIR Health's Opioid Tracker.

14 Oct 2026

Early vasopressin use does not improve septic shock survival

A new study from researchers at Intermountain Health in Salt Lake City found that starting an advanced medication earlier for critically ill patients with life-threatening septic shock does not improve their survival, shorten hospital stays, or improve their recovery compared with waiting until their condition potentially worsens.

14 Oct 2026

New study highlights severe depression risks for young doctor trainees

Every summer, more than 1,600 recent medical school graduates start training to become obstetrician-gynecologists at hospitals across the United States.

14 Oct 2026

Upcoming forum will share patient perspectives on non-cystic fibrosis bronchiectasis care

The Bronchiectasis and NTM Association today announced plans for an Externally-Led Patient-Focused Drug Development (EL-PFDD) meeting for non-cystic fibrosis bronchiectasis (NCFB). This

14 Oct 2026

Biomechanical strain keeps heart valves strong for decades

Collagen plays a critical role in keeping heart valves strong, but the heart is surrounded by enzymes designed to break down collagen.

14 Oct 2026

New immune profiling tool identifies antibodies that trigger preterm births

A typical pregnancy lasts 40 weeks, but for about 1 in 10 pregnant women labor begins too soon. Premature or preterm birth is the leading cause of newborn deaths worldwide.

14 Oct 2026

CSHL researchers find way to make immunotherapy effective against colorectal cancer

Colorectal cancer has become the leading cause of cancer-related death for people under 50. Its most common forms generally aren't treatable, either through conventional means like chemotherapy or newer immunotherapy drugs.

14 Oct 2026

Investigational knee injection targets cartilage loss in osteoarthritis patients

Keck Medicine of USC has launched a clinical trial testing the safety and tolerability of a new investigational treatment and its potential effects on preventing cartilage deterioration in people with knee osteoarthritis, the most common form of the disease.

14 Oct 2026

New eye model guides lighting designs for aging adults

Researchers have developed a new computational model that accounts for the effects of aging on our eyes' ability to discriminate color.

14 Oct 2026

Vocal tract anatomy differences drive the evolution of global languages

The anatomical differences in our vocal tracts could be one of the sources of our Tower of Babel-the vast difference in languages spoken around the world, according to a study published October 13th in the open access journal PLOS Biology by Steven Moran and Tiena Danner from the University of Neuchâtel, Switzerland, and colleagues.

14 Oct 2026

Toxic forever chemicals detected in New Jersey tap and bottled water

Researchers at New Jersey Institute of Technology (NJIT) have found that a largely overlooked class of "forever chemicals" is widespread in New Jersey drinking water and commercially available bottled beverages, raising new questions about how these persistent contaminants are monitored and potentially introduced into everyday products.

14 Oct 2026

Common asthma drug improves strength in children with muscle disease

A common asthma medication improves motor skills and muscle strength in children with congenital myopathies, a group of incurable muscle diseases.

14 Oct 2026

Chronic inflammation spikes during the earliest phase of cardiovascular-kidney-metabolic syndrome

In a nationally representative sample of more than 4,000 American adults, a common marker of inflammation was nearly doubled in people in the first stage of the syndrome, defined by excess or unhealthy body fat, compared with those with no metabolic risk factors.

14 Oct 2026

Finnish study finds poor oral health increases jawbone necrosis risks in breast cancer patients

Antiresorptive drugs, which reduce bone breakdown, are an important part of treatment for breast cancer that has spread to the bones. However, their use can be associated with osteonecrosis of the jaw (MRONJ), a condition in which bone tissue in the jaw dies.

14 Oct 2026

Mosquito saliva study opens new doors for blocking Zika, Dengue, and West Nile infections

Mosquitoes do more than simply transmit the viruses they carry: their saliva may actively help these viruses establish infection in the body from the very moment of the bite.

14 Oct 2026

Seragy launches with €12 million financing to advance quantitative biomarkers for neurodegenerative diseases

seragy holding GmbH (formerly Prosperodes GmbH), a biomarker strategy company focused on neurodegenerative diseases and other proteopathies, has secured €12 million in funding to accelerate the development of its SeRAS® platform (Seed Replication, Analysis and Subtyping) and expand its laboratory and analytical capabilities. The financing is backed by Commerzbank, the Mittelständische Beteiligungsgesellschaft (MBG), and the State of Lower Saxony.

14 Oct 2026